首页> 外文期刊>Translational psychiatry. >Development and validation of a new rating scale for perimenopausal depression—the Meno-D
【24h】

Development and validation of a new rating scale for perimenopausal depression—the Meno-D

机译:开发和验证围绝经期抑郁症的新评估量表Meno-D

获取原文
           

摘要

The menopause transition is a time when women experience an increased risk for new onset depression, as well as relapse of depression. While there are overlapping symptoms between major depression and depression during menopause, differences suggest ‘perimenopausal depression’ may be a unique subtype of depression associated with characteristic symptoms. There is currently no validated scale designed to measure perimenopausal depression. The aim of the current study was to develop and validate the ‘Meno-D’, a self-reporting or clinician rated questionnaire, designed to rate the severity of symptoms of perimenopausal depression. The development phase of the Meno-D involved literature review, clinical observation, and focus groups. A 12-item questionnaire was developed and clinically reviewed for face validity for content. The Meno-D was administered to women experiencing symptoms of perimenopausal depression as part of a larger baseline assessment battery. Validation involved confirmatory factor analysis (CFA). The development of the Meno-D resulted in 12 items. A total of 93 participants with perimenopausal depression were involved in the baseline assessments, 82 completed the Meno-D. Factor analysis identified five sub-scales of the Meno-D “somatic; cognitive; self; sleep; sexual” with high-internal consistency; discriminant validity and a good construct and convergent validity. The Meno-D provides a unique tool for clinicians and researchers to measure the presence of perimenopausal depression.
机译:绝经过渡是女性经历新发抑郁症和抑郁症复发风险增加的时期。尽管绝经期间主要抑郁症和抑郁症之间存在重叠的症状,但差异表明“围绝经期抑郁症”可能是与特征性症状相关的抑郁症的独特亚型。目前尚无经过验证的量表,用于测量围绝经期抑郁症。当前研究的目的是开发和验证“ Meno-D”,这是一种自我报告或由临床医生评定的问卷,旨在评估围绝经期抑郁症状的严重程度。 Meno-D的开发阶段包括文献综述,临床观察和焦点小组。制定了一项12项问卷,并对其内容的面部有效性进行了临床审查。将Meno-D用于出现绝经前抑郁症状的女性,这是更大的基线评估范围的一部分。验证涉及确认性因子分析(CFA)。 Meno-D的开发产生了12个项目。基线评估共有93名绝经后抑郁的参与者参加,其中82名完成了Meno-D。因子分析确定了Meno-D“体细胞;体细胞;体细胞”的五个子量表。认知自;睡觉;性”,具有高度的内部一致性;判别效度,良好的构造和收敛效度。 Meno-D为临床医生和研究人员提供了衡量绝经前抑郁症存在的独特工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号